Study: NCT05127772

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC93077
Description: Paticipants recieve HEC93077 orally single or Mulltiple doses up to 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC93077
Description: Paticipants recieve HEC93077 orally single or Mulltiple doses up to 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC93077
Description: Paticipants recieve HEC93077 orally single or Mulltiple doses up to 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC93077
Description: Paticipants recieve HEC93077 orally single or Mulltiple doses up to 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC93077
Description: Paticipants recieve HEC93077 orally single or Mulltiple doses up to 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC93077
Description: Paticipants recieve HEC93077 orally single or Mulltiple doses up to 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC93077
Description: Paticipants recieve HEC93077 orally single or Mulltiple doses up to 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC93077
Description: Paticipants recieve HEC93077 orally single or Mulltiple doses up to 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC93077
Description: Paticipants recieve HEC93077 orally single or Mulltiple doses up to 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC93077
Description: Paticipants recieve HEC93077 orally single or Mulltiple doses up to 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC93077
Description: Paticipants recieve HEC93077 orally single or Mulltiple doses up to 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC93077
Description: Paticipants recieve HEC93077 orally single or Mulltiple doses up to 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Paticipants recieve placebo matching HEC93077 orally single or Mulltiple doses up to 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Paticipants recieve placebo matching HEC93077 orally single or Mulltiple doses up to 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Paticipants recieve placebo matching HEC93077 orally single or Mulltiple doses up to 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Paticipants recieve placebo matching HEC93077 orally single or Mulltiple doses up to 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Paticipants recieve placebo matching HEC93077 orally single or Mulltiple doses up to 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Paticipants recieve placebo matching HEC93077 orally single or Mulltiple doses up to 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Paticipants recieve placebo matching HEC93077 orally single or Mulltiple doses up to 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Paticipants recieve placebo matching HEC93077 orally single or Mulltiple doses up to 14 days